Serum complement abnormalities in the antinuclear antibody-positive relatives of children with systemic lupus erythematosus. 1979

T J Lehman, and V Hanson, and B H Singsen, and H K Kornreich, and B Bernstein, and K K King

Serum C3, C4 and total hemolytic complement (CH50) levels were measured for 21 children with systemic lupus erythematosus (SLE) and 81 first degree relatives. The mean serum C4 and CH50 levels of the 12 relatives with antinuclear antibodies (ANA( were depressed to levels equal to those of the index cases. A similar depression was not found for C3, nor was there a depression of C3, C4, or CH50 in the relatives without ANA. If preexistent depression of C4 levels can be documented in the ANA-positive relatives of index cases, it may provide an explanation for the inherited predisposition to SLE in some families.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D003181 Complement C4 A glycoprotein that is important in the activation of CLASSICAL COMPLEMENT PATHWAY. C4 is cleaved by the activated COMPLEMENT C1S into COMPLEMENT C4A and COMPLEMENT C4B. C4 Complement,C4 Complement Component,Complement 4,Complement C4, Precursor,Complement Component 4,Pro-C4,Pro-complement 4,C4, Complement,Complement Component, C4,Complement, C4,Component 4, Complement,Component, C4 Complement,Pro C4,Pro complement 4
D005190 Family A social group consisting of parents or parent substitutes and children. Family Life Cycles,Family Members,Family Life Cycle,Family Research,Filiation,Kinship Networks,Relatives,Families,Family Member,Kinship Network,Life Cycle, Family,Life Cycles, Family,Network, Kinship,Networks, Kinship,Research, Family
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear

Related Publications

T J Lehman, and V Hanson, and B H Singsen, and H K Kornreich, and B Bernstein, and K K King
November 1960, Lancet (London, England),
T J Lehman, and V Hanson, and B H Singsen, and H K Kornreich, and B Bernstein, and K K King
February 2012, Pediatrics in review,
T J Lehman, and V Hanson, and B H Singsen, and H K Kornreich, and B Bernstein, and K K King
February 2003, Indian journal of pediatrics,
T J Lehman, and V Hanson, and B H Singsen, and H K Kornreich, and B Bernstein, and K K King
January 1962, Medical bulletin (Ann Arbor, Mich.),
T J Lehman, and V Hanson, and B H Singsen, and H K Kornreich, and B Bernstein, and K K King
March 2022, Cureus,
T J Lehman, and V Hanson, and B H Singsen, and H K Kornreich, and B Bernstein, and K K King
April 1981, The Journal of pediatrics,
T J Lehman, and V Hanson, and B H Singsen, and H K Kornreich, and B Bernstein, and K K King
September 1983, Journal of clinical pathology,
T J Lehman, and V Hanson, and B H Singsen, and H K Kornreich, and B Bernstein, and K K King
October 1982, Journal of clinical pathology,
T J Lehman, and V Hanson, and B H Singsen, and H K Kornreich, and B Bernstein, and K K King
January 2012, Journal of cutaneous medicine and surgery,
T J Lehman, and V Hanson, and B H Singsen, and H K Kornreich, and B Bernstein, and K K King
March 2021, The Medical clinics of North America,
Copied contents to your clipboard!